ACCORD Trial

The ACCORD Trial (Action to Control Cardiovascular Risk in Diabetes) was a major clinical study designed to determine the best ways to manage blood sugar levels in people with type 2 diabetes. It aimed to see if intensive control of blood sugar, blood pressure, and cholesterol could reduce the risk of heart-related issues. The trial found that while tightly controlling blood sugar levels helped some patients, it also increased risks of severe complications in certain individuals. Overall, ACCORD provided valuable insights into diabetes management and its effects on heart health.